Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2023 Earnings Call Transcript May 8, 2023
Aclaris Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44.
Operator: Good day and thank you for standing by. Welcome to Aclaris Therapeutics First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today,...
